Key result
Novel drugs with metabolic effects and device-based procedures, including baroreceptor stimulation and renal sympathetic denervation, represent emerging strategies for hypertension management.
This review summarizes emerging pharmacological and procedural therapies for hypertension management, including renal sympathetic denervation and baroreceptor stimulation.
Answers are grounded in this paper and cite their sources.
Should not yet alter hypertension practice; leaves open the role of novel drugs and devices pending randomized trials.
The paper reviews the data on the novel drugs and procedures for hypertension management. Several directions are discussed: 1) novel drugs including novel pharmacological classes and novel molecules with additional effects on blood pressure and metabolism; 2) novel procedures and novel devices including baroreceptor stimulation and catheter renal sympathetic denervation
No takes yet. Share an insight, caveat, or question.
Кобалава et al. (2013) studied this question. Novel drugs with metabolic effects and device-based procedures, including baroreceptor stimulation and renal sympathetic denervation, represent emerging strategies for hypertension management.
Synapse has enriched 10 related papers. Consider them for comparative context: